Some Men with Prostate Cancer Can Avoid, Delay Harsh Treatments, Study Finds
More men with prostate cancer could afford to delay their treatment, a decades-long study has found, suggesting that active monitoring... Read More
More men with prostate cancer could afford to delay their treatment, a decades-long study has found, suggesting that active monitoring... Read More
HR 4880/S2720 will standardize care for prostate cancer within the Veterans Health Administration Washington, D.C., Dec. 23, 2022 – ZERO... Read More
The latest information about ZERO, Grow & Give, Caregivers, the ZERO Summit, Events, Doc Moyad, and more… Double Your... Read More
NORTH BILLERICA, MA, and INDIANAPOLIS, IN, November 14, 2022 – Lantheus Holdings, Inc. (”Lantheus”) (NASDAQ: LNTH), a company committed to... Read More
QUESTION FROM PROSTATE CANCER SURVIVOR: I’m 68, and have undergone laparoscopic surgery in 2007. I have bladder control 99% of... Read More
The latest information about the Health Equity Symposium, Breast Cancer Awareness Month, Grow & Give, Run/Walks, and more… Donate... Read More
TALZENNA® first PARP inhibitor to demonstrate clinical benefit in combination with XTANDI® in metastatic castration-resistant prostate cancer (mCRPC) Study achieves primary endpoint... Read More
After a routine blood test detected an elevated prostate-specific antigen level, Daryl Wilson underwent further testing that led to him... Read More
In honor of Prostate Cancer Awareness Month, ZERO was featured on the KRDO news station in order to highlight the... Read More
The University of Miami Miller School of Medicine’s Game Changer vehicles, which bring health education and free screenings for many... Read More